DiaCarta Revenue and Competitors
Estimated Revenue & Valuation
- DiaCarta's estimated annual revenue is currently $4.4M per year.
- DiaCarta received $45.0M in venture funding in February 2018.
- DiaCarta's estimated revenue per employee is $77,500
- DiaCarta's total funding is $53M.
- DiaCarta has 57 Employees.
- DiaCarta grew their employee count by -8% last year.
DiaCarta Competitors & AlternativesAdd Company
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Valuation|
What Is DiaCarta?
DiaCarta is a translational genomics and personalized diagnostics company that provides ultra-sensitive detection tools for cancer diagnosis, therapy identification and prognosis monitoring. Our mission is to provide ultra-sensitive and advanced technologies that will redefine the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. To learn more, visit http://www.diacarta.com.keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals
Number of Employees
Employee Growth %
Amgen; Bluebird Bio; Celgene Corporation; Cellectis; DiaCarta; Fate Therapeutics; Gilead Sciences; Juno Therapeutics; Kite Pharma; Merck; Novartis; Pfizer...
PLEASANTON, Calif. , April 7, 2022 /PRNewswire/ -- DiaCarta Inc., a precision molecular diagnostics company and leading developer of novel...
AZ: DiaCarta is a molecular diagnostics company borne out of decades of research in next-generation sequencing (NGS), circulating cell-free DNA...
RICHMOND, Calif.--(BUSINESS WIRE)--DiaCarta today announced that CIO Bulletin has named it among the 30 Fastest Growing Companies ...
BUSINESS WIRE)--DIACARTA, Inc., a precision diagnostic company and leading developer of products for nucleic acid-based detection ...
|Company Name||Revenue||Number of Employees||Employee Growth||Total Funding|
|2018-02-13||$45.0M||B||Fortune Fountain Capital||Article|